Elia Stupka
InvestorManaging Director at Angelini Ventures Β· Venture Partner at First Star Ventures Β· Board director at Genialis
Rome | Singapore
About
Elia Stupka is a founding Managing Director at Angelini Ventures with over 20 years of executive experience in healthcare and life sciences. He was previously on the leadership team of Health Catalyst through its 2019 NASDAQ IPO, and earlier held roles as Senior Director of Data Science at Dana-Farber Cancer Institute, Venture Partner at First Star Ventures, and Director at Boehringer Ingelheim Pharma. Earlier in his career he was a genomics scientist, including work on the first human genome annotation team in Cambridge and co-directing the genomics research center at San Raffaele Hospital in Milan; he holds a PhD in Computer Science from Leiden University and degrees in Biology from the University of York.
ContactΒ· self-published, not guessed
Invests in
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Board director at Genialis
Intro paths
β
In turn, Elia can intro founders to Genialis's investors below.
Genialis's investors Β· 6
Co-founders at Genialis
MΕ 
Miha Ε tajdoharExecutive Officer, Director
RR
Rafael RosengartenChief Executive Officer and Co-founder
LA
Luka AusecExecutive Officer
Experience
- Angelini VenturesManaging Directorcurrent2021 β presentGlobal
- leapcureStrategic Advisorcurrent2020 β present
- First Star VenturesVenture Partnercurrent2019 β presentBoston, Massachusetts, United States
- Duality TechnologiesStrategic Advisorcurrent2019 β presentTel Aviv, Israel
- Entropica LabsStrategic Advisorcurrent2018 β presentSingapore
- Pulse Infoframe Inc.Strategic Advisorcurrent2018 β present
- Reboot RxStrategic Advisorcurrent2018 β presentBoston, Massachusetts, United States
- Alkahest, Inc.Scientific Advisory Board Membercurrent2016 β present
- GenialisMember Board Of Directorscurrent2017 β presentGreater Boston Area
- GenialisStrategic Advisorcurrent2015 β presentSlovenia
- Healx LtdAdvisorcurrent2016 β presentCambridge, United Kingdom
- EspeRare foundationScientific Advisorcurrent2015 β presentGeneva Area, Switzerland
- Health CatalystStrategic Advisor2020 β 2024
- Health CatalystSVP and General Manager - Life Sciences Business2019 β 2020Cambridge, MA
- Health CatalystChief Analytics Officer, SVP - Life Sciences Business2018 β 2019Cambridge, MA
- Cardea Bio Inc.Innovation Councilor2020 β 2023San Diego, California, United States
- WSAFE IMPACT VENTURE BUILDERStrategic Advisor2020 β 2022Ho Chi Minh City, Vietnam
- reach52Advisor2020 β 2022Singapore
- RaremarkAdvisor2018 β 2022London, UK
- United World College of the Adriatic - Collegio del Mondo Unito dell'Adriatico ONLUSBoard Member2016 β 2018
- Dana-Farber Cancer InstituteSenior Director, Data Science and Bioinformatics2017 β 2018Boston, Massachusetts
- UWC Italian National CommitteeBoard Member2016 β 2018Italy
- Boehringer IngelheimDirector2014 β 2017Biberach an der RiΓ
- San Raffaele S.p.A.Co-Director, Center for Translational Genomics and Bioinformatics2011 β 2014Milan Area, Italy
- University College LondonSenior Lecturer, Bioinformatics2009 β 2011
- Barts and The London NHS TrustSenior Lecturer, Bioinformatics2009 β 2011
- CBM S.c.r.l.Manager2006 β 2009
- Telethon Institute of Genetics and MedicineBioinformatics Program Manager2003 β 2006
- IBMLead Consultant2003 β 2005
- Temasek Life Sciences LaboratoryBioinformatics Program Manager2002 β 2003
- Institute of Molecular and Cell BiologyProject Manager2001 β 2002
- European Bioinformatics InstituteScientific Programmer1999 β 2001
Skills & more
Leadership22Strategy23Analysis17Perl38R23Science99Life Sciences99Computational Biology99Bioinformatics99Genomics99Biotechnology76Data Mining67
+12 more
ResearchBusiness DevelopmentData AnalysisGeneticsStart-upsR&DSequence AnalysisTranscriptomicsSystems BiologySequencingRNAseqBiologyLanguages Czech Β· English Β· French Β· Georgian Β· Italian Β· Spanish
From Elia's professional profile.
Investments
Per the firm's website.
Colleagues at Angelini Ventures
Network4
Drew Volpe
Founding Partner at First Star Ventures
Julia SvennerstΓ₯l-Hawkins
General Partner at Phoenix Court
Millie Liu Liu
Founding Partner at First Star Ventures
Teddy Blank
Partner at First Star Ventures
Investors connected to Elia in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Elia Stupka?
- Elia Stupka is a founding Managing Director at Angelini Ventures with over 20 years of executive experience in healthcare and life sciences. He was previously on the leadership team of Health Catalyst through its 2019 NASDAQ IPO, and earlier held roles as Senior Director of Data Science at Dana-Farber Cancer Institute, Venture Partner at First Star Ventures, and Director at Boehringer Ingelheim Pharma. Earlier in his career he was a genomics scientist, including work on the first human genome annotation team in Cambridge and co-directing the genomics research center at San Raffaele Hospital in Milan; he holds a PhD in Computer Science from Leiden University and degrees in Biology from the University of York.
- Where does Elia Stupka work?
- Elia Stupka is Managing Director at Angelini Ventures and Board director at Genialis.
- What does Elia Stupka invest in?
- Elia Stupka invests in AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech.
- What boards does Elia Stupka sit on?
- Elia Stupka holds tracked board seats at Comind, Genialis, Serenis.
- Where did Elia Stupka go to school?
- Elia Stupka studied at MIT Sloan School of Management (Leading Innovative Enterprises Program, Innovation); Leiden University (Doctor of Philosophy (PhD), Computer Science); University of York (M.Res., Biomolecular Science).
Same school
Also attended MIT Sloan School of Management518
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 512 more
Also attended Leiden University78
Andrea van ElsasInvestor at Third Rock VenturesJoost HollemanInvestor at Prime VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at Syncona
+ 72 more
Also attended University of York50
Bob ThomasPartner at OxxNicole QuinnCo-Founder and Managing Partner at Connect VenturesPhil VenablesVenture Partner at Ballistic VenturesAnthony AvedissianPartner at Canonical CryptoConor ScanlanAssociate Partner at Nauta CapitalCharlie LeggatePartner at Anorak Ventures
+ 44 more
Also attended Liceo Scientifico "Galileo Galilei"2
Shared employers
Also worked at reach521
Also worked at Dana-Farber Cancer Institute33
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Dave BarrettSenior Advisory Partner at Polaris PartnersMargaux FosterAnalyst at redalpineWeihan LiuAssociate at Cure VenturesShereef ElnahalObvious Champion at Obvious VenturesRosie BellDirector of Marketing at LRVHealth
+ 27 more
Also worked at San Raffaele S.p.A.3
Also worked at IBM710
Brian ArmstrongCo-founder & CEO of CoinbaseOlivier PomelCo-founder & CEO of DatadogAlexis Le-QuocCo-founder & CTO of DatadogKen ChenaultInvestment Team at General CatalystRoger KrakoffGeneral Partner at Monta Vista CapitalAvi BharadwajInvestment Director at Intel Capital
+ 704 more